Overexpression of cyclooxygenase‐2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.10684PMID 12209745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion

  2003cited by this paper
• Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.

  2001cited by this paper
• Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

  2001influential reference
• Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy.

  2001influential reference
• Why there are two cyclooxygenase isozymes.

  2001cited by this paper
• Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.

  2001cited by this paper
• Expression of Cyclooxygenase-2 in Human Breast Carcinoma: Relevance to Tumor Angiogenesis and Expression of Estrogen Receptor.

  2001cited by this paper
• Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer

  2000cited by this paper
• COX‐2 is expressed in human pulmonary, colonic, and mammary tumors

  2000cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.

  2000cited by this paper
• Cyclooxygenases: structural, cellular, and molecular biology.

  2000cited by this paper
• Increased expression of cyclooxygenase-2 protein in human gastric carcinoma.

  2000cited by this paper
• Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.

  2000cited by this paper
• Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy.

  2000cited by this paper
• Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

  2000cited by this paper
• Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients.

  2000cited by this paper
• High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion.

  2000influential reference
• Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors.

  2000cited by this paper
• Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

  1999cited by this paper
• Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

  1999cited by this paper
• Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.

  1999cited by this paper
• Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

  1999cited by this paper
• The role of cyclooxygenases in inflammation, cancer, and development

  1999cited by this paper
• Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• The relationship between cyclooxygenase-2 expression and colorectal cancer.

  1999cited by this paper
• Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme

  1999cited by this paper
• Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation

  1999cited by this paper
• Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.

  1998cited by this paper
• Expression of cyclooxygenase-2 in human lung carcinoma.

  1998cited by this paper
• Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).

  1998cited by this paper
• Expression of Prostaglandin G/H Synthase Type 1, but not Type 2, in Human Ovarian Adenocarcinomas

  1998cited by this paper
• Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.

  1998cited by this paper
• Subcellular Localization of Prostaglandin Endoperoxide H Synthases-1 and -2 by Immunoelectron Microscopy*

  1998cited by this paper
• Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.

  1997cited by this paper
• Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.

  1997cited by this paper
• Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

  1997cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• ALTERATIONS IN THE

  1985cited by this paper

• EGFR polymorphisms drive lung cancer risk and survival disparities: a genotype-expression-outcome cohort study

  2025cites this paper
• Immunohistochemical Expression Levels of Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Ki-67 in Canine Cutaneous Squamous Cell Carcinomas

  2024cites this paper
• Radiotherapy resistance: identifying universal biomarkers for various human cancers

  2022cites this paper
• EGFR, NF-κB and noncoding RNAs in precision medicine.

  2022cites this paper
• Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients

  2021cites this paper
• E6-regulated overproduction of prostaglandin E2 may inhibit migration of dendritic cells in human papillomavirus 16-positive cervical lesions

  2020cites this paper
• Efficacy of Gefitinib Combined with 125I Radioactive Particles in the Treatment of Transplanted Lung Cancer Tumors in Nude Mice

  2020cites this paper
• Radiolabeled peptide probes for liver cancer imaging.

  2020cites this paper
• Addition of Etoricoxib During Concurrent Chemo-radiation of Cervical Cancer Patients Could Result in Faster Resolution of Gross Disease: A Prospective Single-Institution Study

  2019cites this paper
• Targeting inflammatory mediators: An anticancer mechanism of thymoquinone action.

  2019cites this paper
• Two Novel tri-aryl Derivatives Attenuate the Invasion- Promoting Effects of Stromal Mesenchymal Stem Cells on Breast Cancer.

  2019cites this paper
• The association of changes in RAD51 and survivin expression levels with the proton beam sensitivity of Capan‑1 and Panc‑1 human pancreatic cancer cells.

  2018cites this paper
• Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas

  2017cites this paper
• Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer

  2017cites this paper
• Natural Products Targeting Clinically Relevant Enzymes of Eicosanoid Biosynthesis Implicated in Inflammation and Cancer

  2017cites this paper
• Augmented Activity of Cyclooxygenase‐2 in Tissue and Serum of Patients With Cervical Cancer

  2016cites this paper
• The Effect of High Poly Unsaturated Fatty Acid (PUFA) Dietary Supplementation on Inflammatory Status of Patients with Advanced Cervical Cancer on Radiation Treatment.

  2015cites this paper
• Aberrant regulation of the DNA replication licensing system and genomic instability in penile squamous cell carcinoma

  2015cites this paper
• Design, synthesis and structure–activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs

  2014cites this paper
• COX-2 overexpression and -8473 T/C polymorphism in 3′ UTR in non-small cell lung cancer

  2014cites this paper
• The association between COX-2 expression and survival in myeloma patients.

  2014cites this paper
• Original Article Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression

  2014cites this paper
• Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.

  2014cites this paper
• Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).

  2014cites this paper
• Exploiting Celecoxib in Cancer Therapy

  2014cites this paper
• Mitochondria: The Anti- cancer Target for the Third Millennium

  2014cites this paper
• Inflammation induced by human papillomavirus in cervical cancer and its implication in prevention

  2014cites this paper
• Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.

  2014cites this paper
• Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.

  2014cites this paper
• Immunohistrochemistry Expression of COX-2 as a Prognostic Factor for Survival in Locally Advanced Cervical Cancer Treated with Concurrent Cisplatin-Radiation Therapy

  2014influential citation
• Expression of Ki67, BCL-2, and COX-2 in Canine Cutaneous Mast Cell Tumors

  2013cites this paper
• Prognostic Factors for Carcinoma of the Uterine Cervix Treated with Concurrent-Chemoradiotherapy

  2013cites this paper
• and is an independent predictor of poor outcome Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma

  2013cites this paper
• COX-2 overexpression Induced by gene transfer reduces sensitivity of TE13 esophageal carcinoma cells to 5-fluorouracil and cisplatin.

  2013cites this paper
• Tissue biomarkers as prognostic variables of cervical cancer.

  2013influential citation
• Prognostic significance of cyclooxygenase‐2 in cervical cancer: A meta‐analysis

  2013cites this paper
• Targeting apoptosis pathways by Celecoxib in cancer.

  2013cites this paper
• Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.

  2012cites this paper
• Multifaceted link between cancer and inflammation.

  2012cites this paper
• Prognostic implications of tumor volume response and COX-2 expression change during radiotherapy in cervical cancer patients

  2012cites this paper
• Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy.

  2011cites this paper
• A study on expression pattern of cyclooxygenase-2 in carcinoma of cervix.

  2011cites this paper
• The Effect of HIV and HPV Coinfection on Cervical COX-2 Expression and Systemic Prostaglandin E2 Levels

  2011cites this paper
• Tumor Markers of Neo-Adjuvant Chemo-Radiation Response in Rectal Cancer

  2011cites this paper
• Regulation of polyisoprenylated methylated protein methyl esterase by polyunsaturated fatty acids and prostaglandins.

  2011cites this paper
• Molecular predictive factors of outcome of radiotherapy in cervical cancer.

  2011cites this paper
• Targeting the inflammatory pathways to enhance chemotherapy of cancer

  2011cites this paper
• The Prognostic Importance of EGFR and COX-2 Expression in Cervix Cancer Stages IIb-IVa

  2011cites this paper
• Cyclooxygenase-2 Signaling in Squamous Cell Carcinomas

  2011cites this paper
• Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501).

  2010cites this paper
• Prognostic significance of CD24 protein expression in patients treated with adjuvant radiotherapy after radical hysterectomy for cervical squamous cell carcinoma.

  2010cites this paper
• In reply to Drs. Chen and Liang

  2010cites this paper
• Experimental evidence of a role of COX-2 in carcinogenesis

  2009cites this paper
• Cyclooxygenase‐2 Expression in Cervical Intraepithelial Neoplasia

  2009cites this paper
• Inflammation and cancer: how friendly is the relationship for cancer patients?

  2009cites this paper
• Cyclooxygenase-2 expression in cervical squamous cell carcinoma: the significance of expression in neoplastic cells within the lymphovascular space.

  2009cites this paper
• Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma.

  2009influential citation
• La signification pronostique de l'expression de la cyclooxygénase 2 dans le cancer du larynx glottique de stade précoce traité par radiothérapie

  2009influential citation
• Acute toxicity of cyclooxygenase-2 inhibitor rofecoxib as a radiosensitizer for concurrent chemoradiation in the treatment of uterine cervical cancer.

  2009cites this paper
• Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.

  2009cites this paper
• Role of cyclooxygenase-2 in cervical cancer

  2009cites this paper
• The Effect of Cyclooxygenase-2 Expression on Tumor Volume Response in Patients Treated with Radiotherapy for Uterine Cervical Cancer

  2009influential citation
• Overexpression of cyclooxygenase-2 is associated with chemoradiotherapy resistance and prognosis in esophageal squamous cell carcinoma patients.

  2008cites this paper
• Importance of Bak for celecoxib-induced apoptosis.

  2008cites this paper
• Cyclooxygenase-2 expression as a predictor of para-aortic lymph node recurrence in uterine cervical cancer.

  2008cites this paper
• Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer

  2008cites this paper
• Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.

  2008cites this paper
• The role of COX-2 in rectal cancer treated with preoperative radiotherapy

  2008cites this paper
• Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2

  2008cites this paper
• Anti‐inflammatory agents for preventing the progression of cervical intraepithelial neoplasia

  2008cites this paper
• Prognostic Significance of Cyclooxygenase-2 Overexpression in Glottic Cancer

  2008cites this paper
• Influences of cyclooxygenase-1 and -2 expression on the radiosensitivities of human cervical cancer cell lines.

  2007cites this paper
• Cyclooxygenase 2 Expression in Cervical Intraepithelial Neoplasia and Vulvar Cancer

  2007cites this paper
• Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.

  2007cites this paper
• Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.

  2007cites this paper
• Molecular Genetics of Cervical Cancer

  2007cites this paper
• Cross‐talks between cyclooxygenase‐2 and tumor suppressor protein p53: Balancing life and death during inflammatory stress and carcinogenesis

  2007cites this paper
• Molecular and genetic pathways in penile cancer.

  2007cites this paper
• Cyclooxygenase expressions and response to radiation therapy in uterine cervix cancer

  2006cites this paper
• Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers.

  2006cites this paper
• COX‐1 and COX‐2 expression in stage I and II invasive cervical carcinoma: relationship to disease relapse and long‐term survival

  2006cites this paper
• COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy.

  2006cites this paper
• Uterine Cervix Cancer

  2006cites this paper
• Analyse relevanter Signalwege der strahleninduzierten COX-2 Expression in Tumorzellen

  2006cites this paper
• Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer.

  2006cites this paper
• Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables

  2006cites this paper
• Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy.

  2006cites this paper
• Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis.

  2006cites this paper
• cech biologicznych guza dla jednoczesnej chemioradioterapii nowotworów z ∏ oÊliwych

  2005cites this paper
• Assessment of Cyclooxygenase-2 Expression in Canine Hemangiosarcoma, Histiocytic Sarcoma, and Mast Cell Tumor

  2005cites this paper
• Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.

  2005cites this paper
• Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2.

  2005cites this paper
• Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas

  2005cites this paper
• Prognostic role of cyclooxygenase‐2 in neoadjuvant‐treated patients with squamous cell carcinoma of the esophagus

  2005cites this paper
• COX-1 and COX-2 expression in stage I and II invasive cervical carcinoma: relationship to disease relapse and long-term survival

  2005cites this paper
• Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer.

  2005cites this paper
• Prognostic significance of cyclooxygenase-2 in breast and esophageal carcinoma

  2005cites this paper
• Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus.

  2005cites this paper
• Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

  2005cites this paper
• Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.

  2005cites this paper